论文部分内容阅读
目的观察米非司酮配伍米索前列醇终止带器妊娠≤98 d的临床效果。方法选择带器妊娠妇女85例为治疗组,同时选择未带器妊娠妇女85例为对照组,两组均采用米非司酮和米索前列醇终止妊娠,服药方法相同。结果治疗组85例完全流产占82.35%,不全流产占15.29%,流产失败占2.35%(小数部分和不为1为数值修约所致);对照组85例完全流产占83.53%,不全流产占14.12%,流产失败占2.35%。两组比较差异无统计学意义(P>0.05)。两组流产时及流产后2 h内阴道出血情况比较差异无统计学意义(P>0.05)。结论米非司酮配伍米索前列醇能有效终止带器妊娠,与未带器妊娠流产效果相似,安全、有效,值得临床应用。
Objective To observe the clinical effect of mifepristone combined with misoprostol termination of pregnancy ≤ 98 d. Methods 85 pregnant women with pregnancy were selected as the treatment group. 85 pregnant women without pregnancy were selected as the control group. Both groups received the same treatment with mifepristone and misoprostol. Results In the treatment group, 85 cases of complete abortion accounted for 82.35%, incomplete abortion accounted for 15.29%, miscarriage failed accounted for 2.35% (fractional part and not 1 for the value of repair due to); control group 85 cases of complete abortion accounted for 83.53%, incomplete abortion 14.12%, miscarriage accounted for 2.35%. There was no significant difference between the two groups (P> 0.05). There was no significant difference in vaginal bleeding between the two groups during abortion and 2 h after abortion (P> 0.05). Conclusion Mifepristone combined with misoprostol can effectively terminate the pregnancy with a device, which is similar to the effect of abortion without pregnancy, which is safe and effective and worthy of clinical application.